SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-10-057338
Filing Date
2010-11-23
Accepted
2010-11-23 16:06:09
Documents
3
Period of Report
2010-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd292061.htm 8-K 20336
2 AMENDED AND RESTATED MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENT, DATED AS OF rrd292061_33485.htm EX-10.58 50835
3 AMENDED AND RESTATED MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENT, DATED AS OF rrd292061_33486.htm EX-10.59 52356
  Complete submission text file 0001181431-10-057338.txt   125180
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 101211871
SIC: 2834 Pharmaceutical Preparations